A User’s Guide to Cannabinoid Therapies in Oncology
1
Division of Palliative Care, University of Toronto, Toronto, ON, Canada
2
Division of Palliative Care, McMaster University, Hamilton, ON, Canada
3
Supportive and Palliative Care Program, William Osler Health System, Toronto, ON, Canada
4
St. Boniface Unit, Cancer Care Manitoba, St. Boniface, MB, Canada
5
Department of Internal Medicine and Department of Family Medicine, University of Manitoba, Winnipeg, MB, Canada
6
Winnipeg Regional Health Authority Palliative Care Program, Winnipeg, MB, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2016, 23(6), 398-406; https://doi.org/10.3747/co.23.3487
Submission received: 11 September 2016 / Revised: 12 October 2016 / Accepted: 15 November 2016 / Published: 1 December 2016
Abstract
“Cannabinoid” is the collective term for a group of chemical compounds that either are derived from the Cannabis plant, are synthetic analogues, or occur endogenously. Although cannabinoids interact mostly at the level of the currently recognized cannabinoid receptors, they might have cross reactivity, such as at opioid receptors.
Share and Cite
MDPI and ACS Style
Maida, V.; Daeninck, P.J. A User’s Guide to Cannabinoid Therapies in Oncology. Curr. Oncol. 2016, 23, 398-406. https://doi.org/10.3747/co.23.3487
AMA Style
Maida V, Daeninck PJ. A User’s Guide to Cannabinoid Therapies in Oncology. Current Oncology. 2016; 23(6):398-406. https://doi.org/10.3747/co.23.3487
Chicago/Turabian StyleMaida, V., and P.J. Daeninck. 2016. "A User’s Guide to Cannabinoid Therapies in Oncology" Current Oncology 23, no. 6: 398-406. https://doi.org/10.3747/co.23.3487
